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Abstract
Introduction: Infectious complications are the main causes of postoperative morbidity. The early timing of their
promoting factors is the rationale for perioperative strategies attempting to reduce them. Our aim was to
determine the effects of perioperative haemodynamic goal-directed therapy on postoperative infection rates.
Methods: We performed a systematic review and meta-analysis. MEDLINE, EMBASE, The Cochrane Library and the
DARE databases were searched up to March 2011. Randomised, controlled trials of major surgery in adult patients
managed with perioperative goal-directed therapy or according to routine haemodynamic practice were included.
Primary outcome measure was specific type of infection.
Results: Twenty-six randomised, controlled trials with a combined total of 4,188 participants met our inclusion
criteria. Perioperative goal-directed therapy significantly reduced surgical site infections (pooled OR 0.58, 95% CI
0.46 to 0.74; P < 0.0001), pneumonia (pooled OR 0.71, 95% CI 0.55 to 0.92; P = 0.009), and urinary tract infections
(pooled OR 0.44, 95% CI 0.22 to 0.84; P = 0.02). A significant benefit was found regarding total infectious episodes
(OR 0.40, 95% CI 0.28 to 0.58; P < 0.00001).
Conclusions: Flow-directed haemodynamic therapy designed to optimise oxygen delivery protects surgical
patients against postoperative hospital-acquired infections and must be strongly encouraged, particularly in the
high-risk surgical population.
Introduction
In major surgical patients, infectious complications are
the main cause of morbidity [1,2]. Other than strict
asepsis, antibiotic prophylaxis, avoidance of glucose
imbalance, and normothermia [3], no strategy has been
demonstrated to be effective for their prevention. Even
though postoperative infections are typically not
detected until a few days after surgery, their promoting
factors occur within the first few hours following surgi-
cal insult.
Goal-directed therapy (GDT) is a haemodynamic
treatment based on titration of fluid and inotropic drugs
infused to physiologic flow-related end points [4]. This
regimen was originally applied in surgical patients with
the aim of reaching normal or supranormal values of
cardiac output and oxygen delivery (DO2)t om a n a g e
the perioperative increase in oxygen demand and to pre-
vent organ failure [5]. When performed perioperatively
in high-risk surgical patients, GDT decreases mortality
[6] and postoperative renal and gastrointestinal compli-
cations [7,8]. However, no study on perioperative GDT
has specifically assessed postoperative infections as the
main primary outcome measure.
Therefore, we performed a systematic review including
a meta-analysis about the effects of perioperative GDT
on postoperative infections. We reviewed randomised,
controlled trials (RCTs) to assess the efficacy of GDT
compared with standard haemodynamic management of
postoperative infections in adult surgical patients.
Materials and methods
Eligibility criteria
Studies were searched according to the following elig-
ibility criteria [9]:
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and older) undergoing major surgery were considered.
Studies involving mixed populations of critically ill, non-
surgical patients, or postoperative patients with sepsis or
organ failure were excluded.
2. Types of interventions: GDT was defined as perio-
perative monitoring and manipulation of haemodynamic
parameters to reach normal or supranormal values by
fluid infusion alone or in combination with inotropic
therapy within eight hours after surgery. Studies includ-
ing late haemodynamic optimisation treatment were
excluded.
3. Types of comparisons: Trials comparing the benefi-
cial and harmful effects of GDT and standard haemody-
namic therapy were considered. We excluded RCTs
with no description of or no difference in optimisation
strategies between groups, as well as RCTs in which
therapy was titrated to the same goal in both groups or
was not titrated to predefined end points.
4. Types of outcome measures: The primary outcome
measures were surgical site infections (SSIs), either inci-
sional and organ or space; pneumonia; catheter-related
bloodstream infections (CRBSIs), and urinary tract infec-
tions (UTIs). The secondary outcome measure was the
number of overall postoperative infectious episodes.
5. Types of studies: RCTs on perioperative GDT in
surgical patients were included. No language, publica-
tion date, or publication status restrictions were
imposed.
Information sources
Different search strategies (last update March 2011)
were performed to retrieve relevant studies by using the
MEDLINE, The Cochrane Library and EMBASE data-
bases. No date restriction was applied for searching the
M E D L I N Ea n dT h eC o c h r a n eL i b r a r yd a t a b a s e s ,w h i l e
the search was limited to 2007 to 2011 for searching of
the EMBASE database [10]. Additional RCTs were
searched in The Cochrane Library and the Database of
Abstracts of Reviews of Effects (DARE) databases and in
the reference lists of previously published reviews and
retrieved articles. Other data sources were hand-
searched in the annual proceedings (2003 to 2010) of
the Society of Critical Care Medicine, the European
Society of Intensive Care Medicine, the Society of Cardi-
ovascular Anesthesiologists, the Royal College of Anaes-
thetists and the American Society of Anesthesiologists.
Search terms
Trials selection was performed by using the following
search terms: randomized controlled trial, controlled
clinical trial, surgery, goal directed, goal oriented, goal
target, cardiac output, cardiac index, DO2,o x y g e nc o n -
sumption, cardiac volume, stroke volume, fluid therapy,
fluid loading, fluid administration, optimisation, optimi-
zation, sopranormal, supranormal.
The search strategies used for the MEDLINE, The
Cochrane Library and EMBASE databases are reported
in Additional file 1.
Study selection
Two investigators (MM and LD) first examined each
title and abstract to exclude clearly irrelevant studies
and to identify potentially relevant articles. Other two
investigators (MG and FP) independently determined
the eligibility of full-text articles retrieved. The names of
the authors, institutions, and the journals in which the
articles were published, as well as the RCT’sr e s u l t s ,
were unknown to the two investigators at that time.
Data collection process
Data were independently collected by two investigators
(MG and NB), with any discrepancy being resolved by
reinspection of the original article. To avoid transcrip-
tion errors, the data were input into statistical software
and rechecked by different investigators (FP and LD).
RCT data gathered
Data abstraction included patient characteristics (age
a n ds e x )a n dr i s kf a c t o r s( b a s e do nP h y s i o l o g i ca n d
Operative Severity Score for the Enumeration of Mortal-
i t ya n dM o r b i d i t y-P O S S U Ms c o r e[ 1 1 ] ,A m e r i c a n
Society of Anesthesiologists Physical Status classifica-
tion, age > 60 years and preoperative morbidity), type of
surgery (that is, elective or emergent, abdominal, thor-
acic, vascular and so forth), type of haemodynamic GDT
(monitoring tools, haemodynamic end points and thera-
peutic interventions), incidence (number of infected
patients and number of infectious episodes) and defini-
tion of postoperative infections.
Risk of bias in individual studies
T h eS c o t t i s hI n t e r c o l l e g i a t eG u i d e l i n e sN e t w o r k
(SIGN) checklist for RCTs was used to evaluate the
methodological quality of the RCTs. The SIGN check-
list was independently filled in by two investigators
(MG and MM) and whenever their results differed, the
study was further assessed to reach consensus. In
Table 1, a double-plus sign (++) denotes studies very
unlikely to have bias, a single plus sign (+) indicates
studies in which bias is unlikely and a minus sign (-)
denotes studies with a high risk of bias [12]. A double-
plus sign was assigned to studies that adequately fit all
the criteria of randomisation, concealment, blinding,
intention-to-treat analysis and predefined outcomes. A
single plus sign was given to studies meeting only four
o ft h ef i v ec r i t e r i a .T h ea d e q u a c yo ft h e s ef i v ec r i t e r i a
is strongly associated with bias reduction [13,14].
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Page 2 of 14Table 1 Quality assessment, sample characteristics and intervention details of the included studies
a
Study SIGN
score
SIGN comment Risk
definition
Type of surgery Goal-directed therapy
(tools and goals)
Modality of
optimisation
Bender et al. 1997
[21], USA
- Randomisation and concealment not
clear, not blinded
Elective aortic and vascular PAC: CI ≥ 2.8 L/minute/m
2,8≤ PCWP ≤ 14 mmHg, SVR
≤1,100 dyn/second/cm
5
Fluids and
inotropes
Benes et al. 2010
[22], Europe
++ High risk Major abdominal Vigileo monitor/FloTrac sensor: SVV < 10% Fluids and
inotropes
Bishop et al. 1995
[23], USA
- Randomisation not adequate,
concealment not clear, not blinded
High risk Emergent trauma PAC: CI ≥ 4.5 L/minute/m
2,D O 2 ≥ 670 mL/minute/m
2,
VO2 ≥ 166 mL/minute/m
2
Fluids and
inotropes
Boyd et al. 1993
[24], Europe
- Randomisation and concealment not
clear
High risk Emergent or elective
major abdominal or vascular
PAC: DO2 > 600 mL/minute/m
2 Fluids and
inotropes
Chytra et al. 2007
[25], Europe
+ Randomisation not clear High risk Emergent trauma Oesophageal Doppler: SV optimisation with FTc > 0.35
seconds
Fluids
(noradrenaline
intraoperatively)
Fleming et al. 1992
[26], USA
- Randomisation not adequate, not
blinded, concealment not described
High risk Emergent trauma PAC: CI ≥ 4.5 L/minute/m
2,D O 2 ≥ 670 mL/minute/m
2,
VO2 ≥ 166 mL/minute/m
Fluids and
inotropes
Forget et al. 2010
[27], Europe
++ High risk Major abdominal Masimo SET pulse oximeter: PVI > 13% Fluids
Gan et al. 2002 [28],
USA
++ Elective general, urologic,
gynaecologic
Oesophageal Doppler: SV optimisation with FTc between
0.35 and 0.4 seconds
Fluids
Jhanji et al. 2010
[29], Europe
++ High risk Major elective abdominal LiDCO Cardiac Sensor System: SV > 10% Fluids
Lobo et al. 2000
[30], Brazil
+ Randomisation not clear High risk Elective major abdominal or vascular PAC: DO2 > 600 mL/minute/m
2 Fluids
Lopes et al. 2007
[31], Brazil
+ Randomisation not clear High risk Elective abdominal Radial artery line: ΔPP ≤ 10% Fluids
Mayer et al. 2010
[32], Europe
+ Randomisation not clear High risk Major abdominal Vigileo monitor/FloTrac sensor: CI ≥ 2.5 L/minute/m
2 Fluids and
inotropes
McKendry et al.
2004 [33], Europe
+ Complication not defined Elective cardiac Oesophageal Doppler: SI > 35 mL/m
2 Fluids
Mythen and Webb
1995 [34], Europe
- Randomisation not clear, flow of
patients not described
High risk Elective cardiac Oesophageal Doppler:
SV optimisation and rise in CVP < 3 mmHg
Fluids
D
a
l
f
i
n
o
e
t
a
l
.
C
r
i
t
i
c
a
l
C
a
r
e
2
0
1
1
,
1
5
:
R
1
5
4
h
t
t
p
:
/
/
c
c
f
o
r
u
m
.
c
o
m
/
c
o
n
t
e
n
t
/
1
5
/
3
/
R
1
5
4
P
a
g
e
3
o
f
1
4Table 1 Quality assessment, sample characteristics and intervention details of the included studies
a (Continued)
Noblett et al. 2006
[35], Europe
+ Randomisation not clear Colorectal Oesophageal Doppler: SV optimisation with FTc between
0.35 and 0.4 seconds
Fluids
(catecholamines
intraoperatively)
Pearse et al. 2005
[36], Europe
++ High risk Elective or emergent major general LiDCO Cardiac Sensor System: DO2 > 600 mL/minute/
m
2, SV > 10%
Fluids and
inotropes
Sandham et al. 2003
[37], Canada
++ High risk Elective or emergent major
abdominal, thoracic, vascular, or
orthopaedic
PAC: CI > 3.5 and < 4.5 L/minute/m
2, 550 < DO2 < 600
mL/minute/m
2, MAP > 70 mmHg, PCWP < 18 mmHg
Fluids and
inotropes
Shoemaker et al.
1998 [38], USA
- Not blinded, unclear dropouts and
withdrawals
High risk Emergent or elective major
abdominal
(general or vascular)
PAC: CI > 4.5 L/minute/m
2,D O 2 > 600 mL/minute/m
2,
VO2 > 170 mL/minute/m
2
Fluids and
inotropes
Sinclair et al. 1997
[39], Europe
- Randomisation and concealment not
clear, flow of patients not described
High risk Orthopaedic Oesophageal Doppler: SV optimisation with FTc between
0.35 and 0.4 seconds
Fluids
Smetkin et al. 2009
[40], Europe
- Randomisation not adequate, not
blinded, concealment not described
Elective cardiac PiCCO Plus monitor: ITBVI 850 to 1,000 mL/m, ScvO2 >
60%
Fluids and
inotropes
Valentine et al. 1998
[41], USA
- Randomisation not clear, not blinded Elective aortic PAC: CI ≥ 2.8 L/minute/m
2,8≤ PCWP ≤ 15 mmHg, SVR
≤ 1,100 dyn/second/cm
5
Fluids and
inotropes
Van der Linden et
al. 2010 [42], Europe
++ High risk Vascular Vigileo monitor/FloTrac sensor: CI > 2.5 L/minute/m
2 Fluids and
inotropes
Velmahos et al.
2000 [43], USA
+ Not blinded High risk Emergent trauma Thoracic bioimpedance: CI > 4.5 L/minute/m
2 Fluids and
inotropes
Venn et al. 2002
[44], Europe
++ High risk Orthopaedic Oesophageal Doppler: SV optimisation with FTc > 0.4
seconds
Fluids
Wakeling et al. 2005
[45], Europe
++ Elective major bowel Oesophageal Doppler: SV optimisation and rise in CVP <
3m m H g
Fluids
Wilson et al. 1999
[46], Europe
+ Not blinded High risk Elective major (abdominal, vascular,
urologic)
PAC: DO2 > 600 mL/minute/m
2 Fluids and
inotropes
aCI: cardiac index; CVP: central venous pressure; DO2: oxygen delivery; FTc: flow time-corrected; ITBVI: intrathoracic blood volume index; LiDCO Cardiac Sensor System (Lidco Ltd., Cambridge, UK); MAP: mean arterial
pressure; Masimo SET pulse oximeter (Masimo Corp., Irvine, CA, USA); PAC: pulmonary artery catheter; PCWP: pulmonary capillary wedge pressure; PiCCO Plus monitor (Pulsion Medical Systems, Munich, Germany);
PVI: Pleth variability index; ScvO2: central venous oxygen saturation; SI: stroke index; SIGN: Scottish Intercollegiate Guidelines Network; SV: stroke volume; SVR: systemic vascular resistance; SVV: stroke volume
variation; VO2: oxygen consumption. ++Studies with very unlikely bias; +studies with unlikely bias; -studies with high risk of bias. See materials and methods section for risk definitions.
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4Regarding blinding, those studies in which the out-
come was explicitly predefined, the outcome assess-
ment was blinded, or both, were considered adequately
masked [15]. For every site of infection, a quality-sensi-
tive analysis was performed, including studies with a
low risk of bias (SIGN evaluation ++ or +) and those
with a high risk of bias (SIGN evaluation -), and a sub-
group analysis was planned that included only trials
that enrolled high-risk patients. Moreover, an out-
come-level assessment (sensitivity analysis) was per-
formed, including studies providing definitions
consistent with the Centers for Disease Control and
Prevention (CDC) criteria [16].
Summary measures and planned method of analysis
Meta-analytic techniques (RevMan analytical software
version 5.1.1; Cochrane Collaboration, Oxford, UK)
were used to combine studies using odds ratios (ORs)
and 95% confidence intervals (95% CIs). A statistical
difference between groups was considered to have
occurred if the pooled 95% CI did not include 1 for
the OR. An OR less than 1 favoured GDT compared
with control group. Two-sided P values were calcu-
lated. A random effects model was chosen for all ana-
lyses. Statistical heterogeneity and inconsistency were
assessed by using the Q-test and I
2 test, respectively
[17,18]. When the P value of the Q-test was < 0.10
and/or the I
2 was > 40%, heterogeneity and inconsis-
t e n c yw e r ec o n s i d e r e ds i g n i f i c a n t[ 1 9 ] .W h e ns i g n i f i -
cant heterogeneity and inconsistency were found, the
most heterogeneous study on the basis of the forest
plot was removed and the analysis was redone [20]. In
all main analyses, studies comprising more than half
the pooled number of patients were removed and rea-
nalysis was performed.
For each main outcome measure, calculation of the
number of patients needed to treat (NNT with 95% CI)
to prevent one patient with complications was carried
out using the formula NNT = 1/(RRR × CER), where
RRR is the summary relative risk reduction and CER is
the control event rate for all trials. Statistical power with
an a error of 0.05 was calculated for each main analysis,
and results ≥ 80% were considered adequate.
Results
Study selection
The search strategies that we used identified 2,676
(MEDLINE), 8,545 (Cochrane Library) and 795
(EMBASE) articles. After initial screening and subse-
quent more detailed selection, a pool of 63 potentially
relevant RCTs was identified. The eligibility process
(Figure 1) excluded 37 articles, and therefore 26 RCTs
[21-46] enrolling a total sample of 4,188 patients were
included in our meta-analysis.
Study characteristics
All selected articles described the results of RCTs evalu-
ating the effects of GDT on postoperative morbidity,
including infections as primary or secondary outcomes,
and had a population sample of adult patients under-
going major surgical procedures. Of 26 studies, 21 stu-
dies [21-32,35-38,41-43,45,46] included abdominal
surgery, 3 studies [33,34,40] involved cardiac procedures
a n dt w os t u d i e s[ 3 9 , 4 4 ]i n c l u d e do n l yo r t h o p a e d i c
surgery.
During the period from 1993 to 2010, 16 studies were
performed in Europe [22,24,25,27,29,32-36,39,42,44-46],
7 were conducted in the United States [21,23,
26,28,38,41,43], 2 were carried out in Brazil [31,32] and
1 was performed in Canada [37]. Eighteen studies
reported the incidence of SSIs, fifteen reported the inci-
dence of pneumonia, five reported the incidence of
CRBSIs, and ten reported the incidence of UTIs. Nine-
teen studies had enrolled high-risk patients, and seven-
teen studies had received a SIGN evaluation of + or ++
(see Table 1 for details).
Quantitative data synthesis
SSIs
A total of 320 episodes of SSI were registered: 199 (11%)
of 1,793 occurred in patients randomised to control
treatment and 121 (6.9%) of 1,757 occurred in patients
randomised to the perioperative GDT group. The
pooled OR was 0.58 and the pooled 95% CI was 0.46 to
0.74 (3,550 patients from 18 RCTs; statistical power
100%). The NNT was 24 (95% CI 16.4 to 42.8). No sta-
tistical heterogeneity or inconsistency was detected (Fig-
ure 2). After excluding the largest study [37], the pooled
OR was 0.41 with a pooled 95% CI of 0.29 to 0.59 (P <
0.00001) for 1,644 patients, with no statistical heteroge-
neity found (Q statistic P = 0.90; I
2 = 0%). The beneficial
effect of GDT in reducing SSIs was confirmed by the
quality-sensitive analysis (that is, including only studies
with a low risk of bias) (Figure 2).
Pneumonia
A total of 283 episodes of postoperative pneumonia
were registered: 162 (10%) of 1,590 occurred in the con-
trol group and 121 (7.5%) of 1,605 occurred in the GDT
group. The pooled OR was 0.71 and the pooled 95% CI
was 0.55 to 0.92 (from a total of 3,195 patients in 15
RCTs; statistical power 86%). The NNT was 34 (95% CI
20.8 to 91.6). No statistical heterogeneity or inconsis-
tency was detected (Figure 3). Excluding the largest
study [37] yielded a pooled OR of 0.54 with a pooled
95% CI of 0.38 to 0.78 (from a total of 1,289 patients, P
= 0.001; Q statistic P = 0.99; I
2 = 0%). The quality-sensi-
tive analysis confirmed the positive effect of GDT in
studies with a low risk of bias (Figure 3).
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In five RCTs, fifty-four patients developed CRBSIs: 33
(2.7%) of 1,213 had been randomised to control group
and 21 (1.7%) of 1,235 had been randomised to perio-
perative GDT group. GDT did not reduce the incidence
of CRBSIs. The pooled OR was 0.63 (pooled 95% CI
0.31 to 1.28; statistical power 39%).
UTIs
In 10 RCTs, 44 patients developed UTIs: 31 (6.9%) of
449 had been randomised to control group and 13
(2.8%) of 458 had been randomised to perioperative
GDT group. GDT reduced the incidence of UTIs: the
pooled OR was 0.44 (pooled 95% CI 0.22 to 0.88; statis-
tical power 82%). The NNT was 25 (95% CI 14.6 to
78.7). No statistical heterogeneity or inconsistency was
detected (Figure 4).
The quality-sensitive analysis confirmed the positive
effect of GDT in studies with a low risk of bias (Figure
4). The subgroup analyses (including only high-risk
patients) and the sensitivity analyses (which included
studies providing definitions consistent with the CDC
criteria) confirmed the main results for SSIs, pneumonia
and UTIs (Table 2).
All infectious episodes
In the 26 RCTs, 909 infectious events were reported:
550 (26%) in the 2,115 patients randomised to control
group and 359 (17.3%) in the 2,073 patients rando-
mised to perioperative GDT group. The pooled OR for
the development of infection was 0.40 (pooled 95% CI
0.28 to 0.58; statistical power 100%). The NNT was 12
(95% CI 9.0 to 16.1). Statistically significant heteroge-
neity and inconsistency were detected (Figure 5). After
excluding the largest study [37], leaving a combined
sample of 2,282 patients, the pooled OR was 0.38 and
the pooled 95% CI was 0.26 to 0.56 (P < 0.0001), but
statistically significant heterogeneity was still observed.
Excluding the two most heterogeneous studies [22,36]
yielded a pooled OR of 0.53 with a pooled 95% CI of
0.40 to 0.70 in a combined sample of 3,946 patients (P
< 0.00001; statistical power 99%) and moderate statisti-
cal heterogeneity and inconsistency (Q statistic P =
0.05; I
2 = 34%).
12016 records identified
through database searching
2217 records after duplicates removed
117 records screened
7 additional records identified
through other sources
26 studies included in
qualitative synthesis
63 full-text articles assessed for eligibility 37 full-text articles excluded:
t20: hemodynamic optimization
titrated to the same end-point or 
not titrated to predefined end 
points, or no difference between
groups in the optimization
protocol;
t10: mixed population of
critically ill, not surgical patients, 
with already established sepsis or 
organ failure and undergoing late 
optimization;
t7: no details on incidence of
postoperative infectious
complications in the total sample.
tSSI n=18
tPneumonia n=15
tCRBSI n=5
tUTI n=10 
tTotal infections n=26
54 records excluded
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Figure 1 Outline of studies selection process. Flowchart summarising the procedure of studies selection for the meta-analysis. CRBSI:
catheter-related bloodstream infection; SSI: surgical site infection; UTI: urinary tract infection.
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Patients who undergo major surgery and are managed
with perioperative haemodynamic GDT are protected
against hospital-acquired infectious events. Specifically,
GDT decreases SSIs, pneumonia and UTIs rates, while
no definite conclusions can be drawn regarding CRBSIs.
Surgical patients carry a high overall risk of hospital-
acquired infections (HAIs), mainly because SSIs occur in
addition to non-surgery-specific infections [47]. Despite
improvements in its prevention, SSI remains one of the
most frequent and expensive preventable surgical com-
plications, occurring in up to 20% of all abdominal pro-
cedures and significantly contributing to morbidity, risk
of death and financial costs [48,49]. Of note, among sur-
gical patients, even the risk of acquiring HAIs other
than SSIs is significantly higher than in those patients
who are not exposed to surgery, with pneumonia and
UTIs being the most frequent complications [47].
In surgical setting, several factors contribute to the
likelihood of infection, depending on the complex inter-
play between microbial (degree of contamination and
virulence), patient (immune status), and procedural
characteristics (length of procedure and amount of
damage to tissues). Basically, infections arise from an
imbalanced relationship between bacterial load and
resistance of the host patient in the context of the pro-
cedure-induced systemic inflammatory response. Surgery
per se weakens patient responsiveness, increasing the
risk of infection because of the loss of integrity of skin
and mucous membranes and the impairment of micro-
bicidal activity of the immune cells [50]. In this setting,
perioperative DO2 plays a critical role. It is well known
Study
High risk of bias
Boyd (24)
Mythen (34)
Shoemaker (38)
Smetkin (40)
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.00; Chi² = 0.55, df = 3 (P = 0.91); I² = 0%
Test for overall effect: Z = 1.31 (P = 0.19)
Low risk of bias
Benes (22)
Chytra (25)
Forget (27)
Gan (28)
Lobo (30)
Lopes (31)
Mayer (32)
Mc Kendry (33)
Noblett (35)
Pearse (36)
Sandham (37)
Venn (44)
Wakeling (45)
Wilson (46)
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.07; Chi² = 15.88, df = 13 (P = 0.26); I² = 18%
Test for overall effect: Z = 4.01 (P < 0.0001)
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.00; Chi² = 16.53, df = 17 (P = 0.49); I² = 0%
Test for overall effect: Z = 4.36 (P < 0.0001)
Events
3
0
1
1
5
4
5
8
4
0
3
5
2
0
9
66
0
5
5
116
121
Total
53
30
28
20
131
60
80
41
50
19
17
30
89
51
62
941
30
64
92
1626
1757
Events
4
1
5
3
13
9
9
8
5
2
5
15
5
2
26
83
2
7
8
186
199
Total
54
30
60
20
164
60
82
41
50
18
16
30
85
52
60
965
60
64
46
1629
1793
M-H, Random, 95% CI
0.75 [0.16, 3.52]
0.32 [0.01, 8.24]
0.41 [0.05, 3.66]
0.30 [0.03, 3.15]
0.50 [0.17, 1.42]
0.40 [0.12, 1.40]
0.54 [0.17, 1.69]
1.00 [0.34, 2.98]
0.78 [0.20, 3.10]
0.17 [0.01, 3.78]
0.47 [0.09, 2.42]
0.20 [0.06, 0.66]
0.37 [0.07, 1.95]
0.20 [0.01, 4.19]
0.22 [0.09, 0.53]
0.80 [0.57, 1.12]
0.38 [0.02, 8.25]
0.69 [0.21, 2.30]
0.27 [0.08, 0.89]
0.50 [0.36, 0.70]
0.58 [0.46, 0.74]
Treatment Control Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours  treatment Favours control
Surgical site infections
Figure 2 Surgical site infections. Rates of postoperative surgical site infections for each of the studies with OR and 95% CI data are shown.
The studies were divided into two subgroups, high risk of bias or low risk of bias, according to the SIGN checklist (see materials and methods
section for details). The pooled OR and 95% CI data are shown as the totals. The size of the box at the point estimate of the OR is a visual
representation of the ‘weighting’ of the study. The diamond represents the point estimate of the pooled OR, and the length of the diamond is
proportional to the 95% CI. 95% CI: 95% confidence interval; M-H: Mantel-Hentzel; OR: odds ratio; SIGN: Scottish Intercollegiate Guidelines
Network.
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Page 7 of 14that adequate oxygen tissue levels promote wound heal-
ing and enhance resistance to infections [51-54]. This
occurs because the oxidative burst function of neutro-
phils and the bacterial killing by alveolar macrophages,
the primary defences against infection [55], both strictly
depend on adequate oxygen tissue pressure [51,56].
Indeed, low tissue oxygen tension is among the best-
established predictors of SSIs [57]. Thus, the mainte-
nance of adequate tissue oxygen supply is a crucial step
in promoting an appropriate immunological response to
infection, especially in the setting of major surgery,
which by itself leads to an increase in oxygen demand.
Although high perioperative inspired oxygen administra-
tion represents an appealing tool, clear evidence for its
beneficial effect has not yet been established. Of note, in
the largest trial in which a high fraction of inspired
oxygen has been tested, no influence on postoperative
wound and pulmonary infections was observed [58].
In the present meta-analysis, we found that augment-
ing the bulk of DO2 by means of flow-directed therapy
decreases postoperative infection rates. This finding has
a pathophysiological foundation, at least theoretically. In
the perioperative period, hypovolaemia and reduced car-
diac output trigger musculocutaneous and splanchnic
vasoconstriction, causing hypoperfusion and tissue
hypoxia [1,4,59], which weaken the mucosal immunolo-
gical response and disrupt the gut barrier. Gut barrier
failure could lead to sepsis by means of bacteria translo-
cation and spillover of cytokines into the bloodstream,
damaging distant tissues and altering the host immuno-
logical milieu [60]. In addition, gut ischaemia-reperfu-
sion injury markedly impairs gut-associated lymphoid
Study
High risk of bias
Boyd (24)
Sinclair (39)
Valentine (41)
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.00; Chi² = 0.44, df = 2 (P = 0.80); I² = 0%
Test for overall effect: Z = 0.20 (P = 0.84)
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Heterogeneity: Tau² = 0.00; Chi² = 7.31, df = 11 (P = 0.77); I² = 0%
Test for overall effect: Z = 2.67 (P = 0.008)
Total (95% CI)
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1
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20
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82
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16
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52
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17
60
46
1456
1590
M-H, Random, 95% CI
0.70 [0.21, 2.36]
1.00 [0.06, 17.18]
1.36 [0.29, 6.34]
0.91 [0.37, 2.25]
0.46 [0.13, 1.63]
0.47 [0.20, 1.09]
1.00 [0.14, 7.39]
0.53 [0.12, 2.33]
0.29 [0.05, 1.80]
0.31 [0.03, 3.17]
0.20 [0.01, 4.19]
0.43 [0.19, 1.00]
0.92 [0.64, 1.31]
0.84 [0.07, 9.96]
0.46 [0.09, 2.34]
0.68 [0.24, 1.92]
0.70 [0.53, 0.91]
0.71 [0.55, 0.92]
Treatment Control Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours  treatment Favours control
Pneumonia
Figure 3 Pneumonia. Rates of postoperative pneumonia for each of the studies included are shown along with ORs and 95% CIs. The studies
were divided into two subgroups, high risk of bias and low risk of bias, according to the SIGN checklist (see text for details). The pooled OR and
95% CI are shown as the total. The size of the box at the point estimate of the OR gives a visual representation of the ‘weighting’ of the study.
The diamond represents the point estimate of the pooled OR and the length of the diamond is proportional to the CI. 95% CI: 95% confidence
interval; OR: odds ratio; SIGN: Scottish Intercollegiate Guidelines Network.
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High risk of bias
Shoemaker (38)
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 0.55 (P = 0.59)
Low risk of bias
Benes (22)
Chytra (25)
Lobo (30)
Lopes (31)
Mayer (32)
Pearse (36)
Van der Linden (42)
Venn (44)
Wilson (46)
Subtotal (95% CI)
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Heterogeneity: Tau² = 0.00; Chi² = 6.72, df = 7 (P = 0.46); I² = 0%
Test for overall effect: Z = 2.54 (P = 0.01)
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.01; Chi² = 8.07, df = 8 (P = 0.43); I² = 1%
Test for overall effect: Z = 2.30 (P = 0.02)
Events
1
1
3
3
0
0
0
1
2
2
1
12
13
Total
28
28
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19
17
30
62
40
30
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Events
1
1
13
2
1
1
0
3
1
4
5
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31
Total
60
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82
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16
30
60
17
60
46
389
449
M-H, Random, 95% CI
2.19 [0.13, 36.26]
2.19 [0.13, 36.26]
0.19 [0.05, 0.71]
1.56 [0.25, 9.58]
0.30 [0.01, 7.83]
0.30 [0.01, 7.79]
Not estimable
0.31 [0.03, 3.08]
0.84 [0.07, 9.96]
1.00 [0.17, 5.79]
0.09 [0.01, 0.80]
0.40 [0.19, 0.81]
0.44 [0.22, 0.88]
Treatment Control Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours treatment Favours control
Urinary tract infections
Figure 4 Urinary tract infections. Rates of postoperative urinary tract infections for each of the studies with ORs and 95% CIs. The studies were
divided into two subgroups defined as high risk of bias and low risk of bias, according to the SIGN checklist (see materials and methods section
for details). The pooled OR and 95% CI data are shown as the totals. The size of the box at the point estimate of the OR is a visual
representation of the ‘weighting’ of the study. The diamond represents the point estimate of the pooled OR, and the length of the diamond is
proportional to the 95% CI. 95% CI: 95% confidence interval; OR: odds ratio; SIGN: Scottish Intercollegiate Guidelines Network.
Table 2 Subgroup analysis for postoperative infective complications
a
Analysis Number of
studies
References Treatment
group
(episodes/total
patients)
Control group
(episodes/total
patients)
OR (95%
CI)
P
value
I
2
SSI high-risk patients 13 [22], [24,25], [27], [30-32],
[34], [36-38], [44], [46]
109/1,483 177/1,522 0.48 (0.33
to 0.70)
0.0001 21%
SSI studies providing definitions
consistent with CDC criteria
8 [22], [25], [30-32], [36],
[44,45]
32/362 74/390 0.37 (0.23
to 0.58)
0.0001 0%
Pneumonia high-risk patients 12 [22], [24,25], [30-32], [36,37],
[39], [42], [44], [46]
115/1,444 155/1,428 0.70 (0.54
to 0.91)
0.008 0%
Pneumonia studies providing definitions
consistent with CDC criteria
9 [22], [25], [28], [30-32],
[36,37], [44]
99/1,289 141/1,341 0.70 (0.53
to 0.93)
0.01 0%
UTI high-risk patients 10 [22], [25], [30-32], [36], [38],
[42], [44], [46]
13/458 31/449 0.44 (0.22
to 0.88)
0.02 1%
UTI studies providing definitions
consistent with CDC criteria
7 [22], [25], [30-32], [36], [44] 9/298 24/326 0.45 (0.20
to 0.99)
0.05 0%
a95% CI: 95% confidence interval; CDC: Centers for Disease Control and Prevention; I
2: inconsistency; OR: odds ratio; SSI: surgical site infection; UTI: urinary tract
infection.
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Page 9 of 14tissue (GALT), further weakening extraintestinal muco-
sal immunity and therefore contributing to the patient’s
increased susceptibility to infections [60,61].
A flow-directed haemodynamic therapy aimed at opti-
mising DO2 by preserving or increasing cardiac output
may preserve the microbicidal function of immune cells
and may protect organs particularly at risk for perio-
perative hypoperfusion [8], avoiding gut barrier failure
and GALT impairment. Our results substantiate these
concepts, demonstrating that perioperative GDT using
fluid loading and/or inotropic supports to prevent tissue
hypoxia could protect surgical patients against SSIs,
pneumonia and UTIs.
No study has specifically assessed the effects of preser-
ving cardiac output on SSI rates, although investigators
in a recent meta-analysis concluded that supplemental
hydration by itself, regardless of any specific haemody-
namic target, does not affect the wound infection rate
[62]. However, when the amount of perioperatively
administered fluids is aimed at increasing subcutaneous
oxygen tension, a greater amount of collagen in wound
healing has been observed [63].
Even if the pathophysiology of postoperative pneumo-
nia after major surgery is undoubtedly complex and
multifactorial [64-66], gut failure and bacterial transloca-
tion through the lymphatics and thoracic ducts [67] and
impaired respiratory mucosal immunity by a decrease in
DO2 may have a potential pathogenetic role [68-70].
Our data seem to support this hypothesis: out of 15 stu-
dies reporting pneumonia, 13 involved abdominal sur-
gery, which is itself a predisposing factor for gut
hypoperfusion [71]. It is reasonable to argue that GDT,
by ensuring adequate systemic oxygenation, can protect
against ischaemia-reperfusion injury, thus decreasing the
incidence of respiratory tract infections after severe sur-
gical insults.
Study
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All infectious episodes
Figure 5 Total postoperative infectious episodes. Rates of total postoperative infectious episodes for each of the studies included are shown
along with ORs and 95% CIs. The pooled OR and 95% CI data are shown as the totals. The size of the box at the point estimate of the OR is a
visual representation of the ‘weighting’ of the study. The diamond represents the point estimate of the pooled OR, and the length of the
diamond is proportional to the 95% CI. 95% CI: 95% confidence interval; OR: odds ratio.
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Page 10 of 14In surgical patients, flow-directed haemodynamic ther-
apy aimed at optimising DO2 represents a useful strat-
egy to prevent HAIs. Therefore, perioperative GDT
must be strongly encouraged, particularly in high-risk
surgical patients [72-74], in whom the likelihood of such
complications is great.
Limitations
The main limitations of all meta-analyses include
reporting bias and the clinical and methodological het-
erogeneity of the included studies. To reduce reporting
bias, we attempted to identify, retrieve and include all
reports, grey and published [75], that met predefined
inclusion criteria, and to retrieve unpublished data by
contacting the authors of the included studies. No
unpublished results were retrieved, and two abstracts
[76,77] were identified, but they did not report the inci-
dence of postoperative infections. Therefore, we cannot
exclude the possible existence of any publication bias,
and available statistical tests are not accurate enough to
detect it [78].
All the studies of perioperative haemodynamic optimi-
sation had the same starting point, fluid loading, and
the same end point, achieving adequate DO2. However,
the included studies varied in their approaches to the
timing and modalities of interventions, the therapeutic
targets, the monitoring tools used and the type of
patients enrolled. Therefore, the clinical heterogeneity of
the studies included in the present meta-analysis may be
relatively high, although the statistical heterogeneity was
low and the main results remained consistent across a
number of subgroups and sensitivity analyses.
The paper by Mayer et al. [32] has been under investi-
gation for ethical reasons because of its link to J Boldt.
However, differently from other papers, their article had
Institutional Review Board approval, and its publication
was not retracted. Therefore, since it remained part of
the scientific record at the time we searched the litera-
ture, we had no sound reason to remove this paper
from our meta-analysis. However, to verify potential
biases in our results, all data were reexamined without
including the Mayer et al. [32] paper, and no differences
were found.
Each type of infection (SSI, pneumonia, CRBSI and
UTI) was considered separately, and a quality sensitive
analysis was performed, including studies with low risk
of bias (SIGN evaluation + or ++). Considering SSIs, the
14 studies reaching a low risk of bias evaluation drove
the significant effect of GDT in reducing wound infec-
tions, assuring reliable and consistent evidence-based
results. The four trials with a high risk of bias did not
demonstrate significant results. For pneumonia, 12 of 15
studies reached a low risk of bias evaluation: The qual-
ity-sensitive analysis including only these studies
confirmed the main result. The lack of outcome defini-
tion is another critical source of bias. In 10 and 6 stu-
dies, respectively, of the present meta-analysis, SSI and
pneumonia were not defined. When we pooled only the
studies in which the definition of SSI and pneumonia
was consistent with the CDC criteria, the analyses con-
firmed the main results.
The pathogenesis of postoperative infections is multi-
factorial, involving the type of surgery, bacterial contam-
ination and host response. Surgery itself and surgical
gut manipulation are major proinflammatory stimuli
[71]. All anaesthetic drugs, especially the opioids, have
the potential to contribute to decreased immune
response [79]. Moreover, glucose and electrolyte imbal-
ance and hypothermia may affect immune function. We
cannot state how all these conditions, comorbidities,
antibiotic prophylaxis and iatrogenic interventions inter-
act to determine infectious complications in the post-
operative period.
Regarding the overall number of infectious episodes,
methodological differences, including the control of cov-
ariates and, above all, the extreme variability in out-
comes, may explain the presence of statistical
heterogeneity and inconsistency in this result. No signif-
icant differences in CRBSIs were observed between the
GDT and control groups. The very low statistical power
of these analyses, owing to the low event rate, may
explain this finding and does not allow us to draw any
meaningful clinical conclusions, so further trials are
needed.
Research agenda
Because of the variability in methodologies and defini-
tions of infections between studies, further prospective,
randomised, controlled studies are warranted to investi-
gate the relationship between haemodynamic GDT and
infection reduction. Specifically, further studies should
incorporate a rigorous protocol that includes all evi-
dence-based approaches to reducing postoperative infec-
tions, standardises perioperative haemodynamic
management and adopts a widely accepted and clinically
relevant definition of ‘postoperative infection’ for each
specific site as a primary end point. Moreover, since
very recent evidence [80] supports clinical benefits and
cost savings of GDT when an oesophageal Doppler
monitor is used in high-risk surgical patients, further
research should be done to investigate the specific role
of this less invasive monitoring device in reducing post-
operative infections.
Conclusions
Infection surveillance, control and prevention systems
have been developed at many centres worldwide, and
numerous guidelines have been published and
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Page 11 of 14implemented in the effort to reduce the incidence of
infections. Despite these measures, the clinical and
economic burden of postoperative infections remains
significant [1,2]. Our meta-analysis, within the limita-
tions of existing data and the analytic approaches
used, shows that GDT is an effective tool in reducing
the incidence of infectious complications, and, more
specifically, that GDT significantly decreases the rate
o fS S I s ,p n e u m o n i aa n dU T I s .D u r i n gs u r g e r y ,G D T ,
by preserving or increasing cardiac output, may pro-
tect patients against severe gut ischaemia-reperfusion
injury and GALT impairment, thus decreasing the
incidence of postoperative infections. Hence, this
strategy must be strongly encouraged. Continuing
investigations into this fundamental area are war-
ranted to better understand the link between haemo-
dynamic optimisation and improved outcomes in
surgical patients.
Key messages
￿ In surgical patients, a flow-directed haemodynamic
therapy aimed to optimise DO2 could be a useful
strategy to prevent hospital-acquired infections.
￿ Specifically, goal-directed haemodynamic therapy
significantly decreases the rate of surgical site infec-
tions, pneumonia and urinary tract infections.
￿ Thus, this strategy must be strongly encouraged,
particularly in the setting of surgical patients at high
risk for infections.
￿ Continuing investigations into this area are war-
ranted to better clarify the link between haemody-
namic optimisation and improved outcome in
surgical patients.
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